The low volumes are exactly what I would expect as buyers are having to meet the Sellers Price. Shareholders expectations are being realized. I see value here, you must have at some stage? as I see you are a Holder. Information with Biotechs is cyclical surrounding Phase I and PhaseII trials. So I don't expect to hear a lot of chatter, I expect Quality announcements that grab market attention and draw new investors attention to the Company. PAA have performed well for those that came in through out March. Plus they have demonstrated the ability to gain real cut through with their media. For a small Biotech they make a lot of News.
The low volumes are exactly what I would expect as buyers are...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.005(2.78%) |
Mkt cap ! $73.24M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.0¢ | 18.3¢ | $334.1K | 1.802M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 111778 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 104266 | 4 |
View Market Depth
| Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
18.5¢ |
Change
0.005 ( 2.78 %) |
||||
| Open | High | Low | Volume | ||
| 18.5¢ | 19.0¢ | 18.0¢ | 1184237 | ||
| Last updated 15.57pm 16/05/2024 ? | |||||
| PAA (ASX) Chart |